BioNTech SE annual stock-based compensation
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE Stock-Based Compensation Growth & History (BNTX)
BioNTech SE's stock-based compensation was €106.3M for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €106.3M | €5.4M | +5.35% |
| 2024 | 2024-12-31 | €100.9M | €49.5M | +96.30% |
| 2023 | 2023-12-31 | €51.4M | −€56.6M | −52.41% |
| 2022 | 2022-12-31 | €108.0M | €14.3M | +15.26% |
| 2021 | 2021-12-31 | €93.7M | €60.9M | +185.67% |
| 2020 | 2020-12-31 | €32.8M | €2.6M | +8.61% |
| 2019 | 2019-12-31 | €30.2M | €22.6M | +295.24% |
| 2018 | 2018-12-31 | €7.6M | €1.7M | +29.31% |
| 2017 | 2017-12-31 | €5.9M | — | — |
BioNTech SE quarterly stock-based compensation
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €20.9M | −€11.2M | −34.89% |
| Q1 2026 | 2026-03-31 | €22.8M | — | — |
| Q4 2025 | 2025-12-31 | €24.1M | — | — |
| Q3 2025 | 2025-09-30 | €27.9M | — | — |
| Q2 2025 | 2025-06-30 | €32.1M | — | — |
BioNTech SE stock-based compensation trends
Over the last five fiscal years, BioNTech SE's stock-based compensation increased from €32.8M to €106.3M, a change of €73.5M. The latest reported quarter, Q2 2026, shows €20.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗